{
  "abstract": "Background: Current evidence highlights the need for appropriate diagnosis and therapy to improve outcomes in people with mild autonomous cortisol secretion (MACS). We aimed to validate the clinical sex-specific significance of the novel diagnosis MACS by characterizing patients according to morbidity and mortality in a real-world setting.\n\nMethods: This retrospective single-center cohort study included clinical data from 670 adult patients with adrenal adenomas undergoing diagnostic workup regarding adrenal hypercortisolism at the Vienna General Hospital from 01.01.2000 to 31.12.2022. For mortality analyses, follow-up data spanning over 20 years was available, patients alive after 01.12.2024 were censored. Patients were classified into 3 groups based on post 1mg-DST cortisol levels (≤1.8µg/dL (suppressed 1mg-DST); &gt;1.8 to ≤5µg/dl (mildly elevated 1mg-DST); &gt;5µg/dL (markedly elevated 1mg-DST)) and analyzed according to cortisol-associated morbidity and mortality.\n\nResults: Compared to those with suppressed 1mg-DST, patients with mildly elevated 1mg-DST were more frequently diagnosed with cortisol-associated diseases like cardiovascular disease (CVD) and osteoporosis while patients with markedly elevated 1mg-DST had more frequently arterial hypertension (aHTN) and osteoporosis, particularly women. Patients with mildly elevated 1mg-DST exhibited the highest mortality, despite comparable prevalence rates of cortisol-associated comorbidities between the mildly and the markedly elevated 1mg-DST group, even after adjusting for age, sex, BMI and cardiometabolic risk factors (HR 1.57 ( 95% CI: 1.01-2.45)). This was attenuated after additional adjustment for cancer history.\n\nConclusion: We identified the mildly elevated 1mg-DSTgroup as a high-risk formerly overlooked cohort, characterized by increased morbidity and mortality. Further prospective studies are needed to clarify the underlying mechanisms and the potential role of cortisol-specific treatment.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Internal Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna",
    "Department of Laboratory Medicine, Medical University of Vienna"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 11,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Luise Bellach"
    },
    {
      "affs": [
        0
      ],
      "name": "Dorota Sluková"
    },
    {
      "affs": [
        0
      ],
      "name": "Dorothea Kalender"
    },
    {
      "affs": [
        0
      ],
      "name": "Sarah Hofer-Zeni"
    },
    {
      "affs": [
        0
      ],
      "name": "Liliana Gard"
    },
    {
      "affs": [
        0
      ],
      "name": "Sabina Baumgartner-Parzer"
    },
    {
      "affs": [
        1
      ],
      "name": "Rodrig Marculescu"
    },
    {
      "affs": [
        0
      ],
      "name": "Greisa Vila"
    },
    {
      "affs": [
        0
      ],
      "name": "Peter Wolf"
    },
    {
      "affs": [
        0
      ],
      "name": "Alexandra Kautzky-Willer"
    },
    {
      "affs": [
        0
      ],
      "name": "Michael Leutner"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/d26m2jah52jrq.bib",
  "cited_by": 0,
  "doi": "10.3389/fendo.2026.1913679",
  "fulltext_url": null,
  "id": "d26m2jah52jrq",
  "issns": [
    "1664-2392"
  ],
  "landing_url": "https://www.frontiersin.org/articles/10.3389/fendo.2026.1913679/full",
  "language": null,
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [],
  "openalex": null,
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-16",
  "publisher": "Frontiers Media SA",
  "ris": "https://research.draconitic.com/paper/d26m2jah52jrq.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:26:02Z",
      "native_id": "10.3389/fendo.2026.1913679",
      "source": "crossref",
      "url": "https://www.frontiersin.org/articles/10.3389/fendo.2026.1913679/full"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "issn:1664-2392",
      "subfield": "endocrinology-metabolism"
    }
  ],
  "title": "Higher mortality in patients with milder autonomous cortisol secretion",
  "title_text": "Higher mortality in patients with milder autonomous cortisol secretion",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:26:02Z",
  "url": "https://research.draconitic.com/paper/d26m2jah52jrq",
  "venue": "Frontiers in Endocrinology",
  "versions": []
}